Drawing for R AND R

USPTO serial 78815929

R AND R

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
GAYNOR, BARBARA ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with R AND R?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer J. Baumann

Jennifer J. Baumann DLA Piper LLP (US)P.O.Box 64807Chicago, IL 60664-0807UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, contouring the face, and for treating hyper functional facial lines, glabellar lines, facial and other wrinkles, asymmetries, defects, and conditions of the human skin; and kits containing two or more syringes prefilled with pharmaceutical preparations for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, contouring the face, and for treating hyper functional facial lines, glabellar lines, facial and other wrinkles, asymmetries, defects, and conditions of the human skinACTIVE
010Injectable medical devices, namely, implants consisting of artificial materials and implants consisting of artificial materials combined with biological materials, all for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, contouring the face, and for treating hyper functional facial lines, glabellar lines, facial and other wrinkles, asymmetries, defects, and conditions of the human skin; and kits containing two or more injectable medical devices, namely, implants consisting of artificial materials and implants consisting of artificial materials combined with biological materials, all for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, contouring the face, and for treating hyper functional facial lines, glabellar lines, facial and other wrinkles, asymmetries, defects, and conditions of the human skinACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 24, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 24, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 12, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2009EX2GSOU EXTENSION 2 GRANTED
Jan 15, 2009EXT2SOU EXTENSION 2 FILED
Jan 15, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2008EX1GSOU EXTENSION 1 GRANTED
Jul 29, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 17, 2008EXT1SOU EXTENSION 1 FILED
Jul 17, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2008CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 8, 2008COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 21, 2008ICNANOTICE OF ALLOWANCE CORRECTION ENTERED
Feb 15, 2008MAILPAPER RECEIVED
Feb 6, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 22, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 30, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 2007NPUBNOTICE OF PUBLICATION
Sep 25, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 25, 2007ALIEASSIGNED TO LIE
Aug 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2007XAECEXAMINER'S AMENDMENT ENTERED
Aug 22, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 22, 2007GNEAEXAMINERS AMENDMENT E-MAILED
Aug 22, 2007CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 26, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 26, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 6, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2006DOCKASSIGNED TO EXAMINER
Feb 23, 2006NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance